- Gestational Diabetes: Recommended for pregnant women without a prior history of diabetes to evaluate the risk of preeclampsia and gestational diabetes, which may occur concurrently during pregnancy.
- Pregancy First Trimester: Suitable for expectant mothers to broadly evaluate pregnancy health during the first trimester and plan appropriate care for subsequent stages.
- NIPT: Suitable for pregnant women seeking comprehensive assessment of genetic risks that may affect fetal development.
- Pregnancy TORCH: Recommended for expectant mothers with weakened health to screen for infections potentially detrimental to pregnancy progression.
Fasting is not required. Mothers can eat, drink and carry out activities normally before the test.
Testing for preeclampsia during the second trimester (from the 13th to 26th week) is essential to detect early risks, especially for women with a history of preeclampsia, chronic hypertension or kidney disease. Key tests include measuring Placental Growth Factor (PIGF), Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) and the sFlt-1/PIGF ratio. The test results help manage and adjust medical care promptly, ensuring the health of both mother and fetus.
Although preeclampsia typically occurs from the 20th week of pregnancy (second trimester), testing in the first trimester can help screen for early risks. This is crucial for preventing the dangerous complications of preeclampsia. In addition to the PlGF index, the risk assessment will be based on various factors such as age, height, weight, mean arterial pressure, mean uterine artery pulsatility index and medical history (diabetes, hypertension, autoimmune diseases...).
Preeclampsia tests focus on analyzing the following indices: Placental Growth Factor (PIGF), Soluble FMS-Like Tyrosine Kinase-1 (sFlt-1) and the sFlt-1/PIGF ratio. Low PlGF level, high sFlt-1 level and high sFlt-1/PlGF ratio exceeding the safe threshold are signs of preeclampsia risk.
The exact cause of pre-eclampsia is currently not well understood. However, pregnant women are assessed for preeclampsia based on various risk factors: age of 35 or older; body mass index (BMI) over 30; multiple pregnancies; history of preeclampsia in previous pregnancies; type 1 or type 2 diabetes; and current or past conditions such as diabetes, kidney disease, hypertension, lupus and antiphospholipid syndrome.
The signs of preeclampsia include hypertension, edema (especially in the hands and face), proteinuria, severe headaches, visual disturbances, upper abdominal pain (under the right rib), nausea or vomiting, reduced urine output, and sudden weight gain.
Preeclampsia can lead to complications for the pregnant woman, including placental abruption, pulmonary edema, multiorgan damage and cerebral hemorrhage. The mother may develop HELLP syndrome, characterized by hemolysis, elevated liver enzymes, low platelet count, hypertension, and proteinuria. Complications of preeclampsia for the fetus can include restricted growth, oligohydramnios, or stillbirth.
Preeclampsia In First Trimester:
- If DIAG's lab receives the sample before 9:00 AM (Mon - Sat), test results will be available at 3:30 PM on the same day.
- If DIAG's lab receives the sample after 9:00 AM (Mon - Sat), test results will be available the next day.
Preeclampsia In 2nd & 3rd Trimester:
- If DIAG's lab receives the sample before 9:00 AM (Mon - Sat), test results will be available after 6 hours on the same day.
- If DIAG's lab receives the sample after 9:00 AM (Mon - Sat), test results will be available at 11:00 AM the next day.